NVO submits higher-dose Wegovy to EMA, aiming for greater weight loss and stronger defense against rivals in the obesity ...

People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...

Novo Nordisk is banking on its pen-filled device and insulin leadership in India to gain a strong market share despite ...

Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...

From legal pitfalls to temperature-sensitive drugs, here’s how to travel safely and legally with your medication ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

EXPERTS have revealed there could be a ‘golden dose’ of Mounjaro that helps shift the most weight – and it’s not the highest ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a ...

You can bring needles and injectable medicines like EpiPens (for allergies), insulin or Wegovy in your hand luggage. But it’s important to carry a doctor’s note stating your medical condition and the ...

Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...